Barclays Maintains an 'Overweight' on Dun & Bradstreet (DNB); Asking The Tough Questions
Tweet Send to a FriendGet Alerts DNB Hot Sheet
Price: $98.98 +1.23%
Rating Summary:
0 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
0 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade DNB Now!
Barclays maintains an 'Overweight' on Dun & Bradstreet (NYSE: DNB) price target lowered from $92 to $80.
Analyst, Manav Patnaik, said, "DNB is economically sensitive and 1Q12 showed it. The impact on the shares, while might seem overdone, was likely deserved as (1) its core North America (N.A.) Risk management (RMS) business was the area of weakness and (2) the company still does not have a clear path of new product innovation to reinvigorate this unit (at least not in 2012)."
Patnaik did however, bring up a critical point to DNB management...is the company better off private? Patnaik believes opportunities exist for the company, but feels DNB management need to re-assess valuation, calling this 're-assessment' the barrier to a sale.
FY12 EPS estimates are lowered from $6.51 to $6.43, but FY13 are raised from $7.16 to $7.25.
In the end, the Barclays analyst, said that any investor with a long-term time horizon, may consider accumulating shares at current levels.
For an analyst ratings summary and ratings history on Dun & Bradstreet click here. For more ratings news on Dun & Bradstreet click here.
Shares of Dun & Bradstreet closed at $63.34 yesterday, with a 52 week range of $58.50-$86.52.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Manav Patnaik, said, "DNB is economically sensitive and 1Q12 showed it. The impact on the shares, while might seem overdone, was likely deserved as (1) its core North America (N.A.) Risk management (RMS) business was the area of weakness and (2) the company still does not have a clear path of new product innovation to reinvigorate this unit (at least not in 2012)."
Patnaik did however, bring up a critical point to DNB management...is the company better off private? Patnaik believes opportunities exist for the company, but feels DNB management need to re-assess valuation, calling this 're-assessment' the barrier to a sale.
FY12 EPS estimates are lowered from $6.51 to $6.43, but FY13 are raised from $7.16 to $7.25.
In the end, the Barclays analyst, said that any investor with a long-term time horizon, may consider accumulating shares at current levels.
For an analyst ratings summary and ratings history on Dun & Bradstreet click here. For more ratings news on Dun & Bradstreet click here.
Shares of Dun & Bradstreet closed at $63.34 yesterday, with a 52 week range of $58.50-$86.52.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Cisco (CSCO) PT Raised to $26.50 at Nomura
- Goldman Sachs Describes Cisco (CSCO) Q3 as 'Breakout Performance'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
